Close Menu

5AM Solutions

The custom software development company will soon test a tool called 5AM Sunrise for managing and aggregating clinical and molecular data.

NEW YORK (GenomeWeb News) – Becton Dickinson this week said its board has declared a quarterly dividend of $.545 per share payable on Dec. 31 to shareholders of record on Dec. 10. At the current rate, the annual dividend for Fiscal Year 2014 would be $2.18 per share, the company said.

5AM Solutions will develop software that will allow Asterand to electronically link multiple biorepositories and identify, annotate, and distribute biospecimen data internally and with collaborators.

The plugin, dubbed SNPTips, allows users to compare their 23andMe raw genetic information with SNP data from publicly available resources, such as databases and journal articles.

The company has opened a San Francisco office to provide bioinformatics development and analysis services to life science customers in the area.

TGen and 5AM are partnering on bioinformatics under a grant from the National Cancer Institute, which makes TGen an In Silico Research Center of Excellence.

Oxford Gene Tech, Optra Systems, Genedata, Syngenta, Floragenex, National Center for Genome Resources, GenoLogics, Genstruct, Gene Logic, Arizona Biomedical Research Commission, 5AM Solutions

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.